Our Science: Communications
Oral communications:
​
- E. BESTEL, E. KARA, D. COQUOZ, R. FRYDMAN, M.C. MAUREL.
IGX12, an FSH-potentiating innovative therapeutic antibody for use in male and female infertility, showed good tolerability in a first-in-human, single ascending dose study.
ESHRE 41st Annual meeting. Paris, France. 29 June- 2 July 2025.
​
​
- E. KARA, J. DECOURTYE, L. DUPUY, S. CASTERET, P. BOUCHARD, R. FRYDMAN, M.C. MAUREL.
A first in class anti-Follicle Stimulating Hormone potentiating therapeutic antibody as a breakthrough treatment for fertility.
Antibody Industrial Symposium. Tours, France. 25-26 June 2025.
​
​
- E. KARA, J. DECOURTYE, L. DUPUY, S. CASTERET, P. BOUCHARD, R. FRYDMAN, M.C. MAUREL.
A first in class monoclonal antibody to treat male infertility.
Nordic Fertility Innovation 2024. Riga, Latvia. 26-27 January 2024.
​
​
- E. KARA, J. DECOURTYE, L. DUPUY, S. CASTERET, M.C. MAUREL.
Modulation of FSH activity with potentiating antibodies.
ICGR-IV Fourth International Conference on Gonadotropins and Receptors. Modena, Italy. 20-23 September 2017.
​
​
- E. KARA, J. DECOURTYE, L. DUPUY, S. CASTERET, M.C. MAUREL.
Modulation of gonadotropins activity with potentiating antibodies.
ICGR-III Third International Congress on Gonadotropins and Receptors. Tours, France. 7-10 September 2014.
​
​
​Poster:
- E. KARA, J. DECOURTYE, S. CASTERET, L. DUPUY, P. BOUCHARD, R. FRYDMAN, M.C. MAUREL.
A first in class potentiating therapeutic antibody as a new male fertility treatment.
ESHRE 40th Annual meeting. Amsterdam, The Netherlands. 7-10 July 2024.
​
​
- E. KARA, J. DECOURTYE, S. CASTERET, L. DUPUY, R. FRYDMAN, M.C. MAUREL.
A first in class potentiating therapeutic antibody as a new treatment for female fertility.
ESHRE 40th Annual meeting. Amsterdam, The Netherlands. 7-10 July 2024.
​
​
- E. KARA, J. DECOURTYE, S. CASTERET, L. DUPUY, R. FRYDMAN, M.C. MAUREL.
Increasing the efficacy of FSH with a potentiating monoclonal antibody.
ESHRE 38th Annual meeting. Milan, Italy. 3-6 July 2022.​​